Concepedia

Wenli Zhang

WZ

Statistics

Publications

15

Citations

578

H-Index

12

Active since

2003

Affiliations

Peking University Shenzhen Hospital(Current)

Chengdu Military General Hospital

Stony Brook School

University of Macau

Sun Yat-sen University

Wenli Zhang is an author at Peking University Shenzhen Hospital specializing in life sciences, immunology, and oncology.

ORCID

Publications per year

2003–2025

15

Publications

15

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Weijia Wang, Shanzhi He, Wenli Zhang et al. · Annals of the Rheumatic Diseases · 2024 · 196 citations

, , +17

Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells

Jia Feng, Hai-chan Xu, Andrew Cinquina et al. · Stem Cell Reviews and Reports · 2021 · 76 citations · Full text

, , +13

Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing

Wei Li, Binglei Zhang, Weijie Cao et al. · Experimental Hematology and Oncology · 2023 · 61 citations · Full text

, , +16

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies

M. Wada, Hongyu Zhang, Fang Liu et al. · Stem Cell Reviews and Reports · 2020 · 37 citations

, , +14

Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis

Dongqin Yang, Qi Zhang, Yunfang Ma et al. · EBioMedicine · 2019 · 29 citations · Full text

, , +16

1–5 of 15